Advertisement
UK markets closed

  • FTSE 100

    8,213.49
    +41.34 (+0.51%)
     

  • FTSE 250

    20,164.54
    +112.21 (+0.56%)
     

  • AIM

    771.53
    +3.42 (+0.45%)
     

  • GBP/EUR

    1.1652
    -0.0031 (-0.26%)
     

  • GBP/USD

    1.2546
    +0.0013 (+0.11%)
     

  • Bitcoin GBP

    50,915.49
    +571.18 (+1.13%)
     

  • CMC Crypto 200

    1,359.39
    +82.41 (+6.45%)
     

  • S&P 500

    5,127.79
    +63.59 (+1.26%)
     

  • DOW

    38,675.68
    +450.02 (+1.18%)
     

  • CRUDE OIL

    77.99
    -0.96 (-1.22%)
     

  • GOLD FUTURES

    2,310.10
    +0.50 (+0.02%)
     

  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     

  • HANG SENG

    18,475.92
    +268.79 (+1.48%)
     

  • DAX

    18,001.60
    +105.10 (+0.59%)
     

  • CAC 40

    7,957.57
    +42.92 (+0.54%)
     
MONEY:

Best savings accounts that offer above inflation rates

Where to find a top-rated deal that works for you

Plexus (PLXS) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Zacks Equity Research
·2-min read

Plexus (PLXS) reported $966.9 million in revenue for the quarter ended March 2024, representing a year-over-year decline of 9.7%. EPS of $0.94 for the same period compares to $1.45 a year ago.

The reported revenue represents a surprise of +1.64% over the Zacks Consensus Estimate of $951.35 million. With the consensus EPS estimate being $0.87, the EPS surprise was +8.05%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

ADVERTISEMENT

Here is how Plexus performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Revenue- Market Sector- Healthcare/Life Sciences: $379 million compared to the $361.74 million average estimate based on two analysts. The reported number represents a change of -22.3% year over year.

  • Revenue- Market Sector- Aerospace/Defense: $170 million compared to the $162.24 million average estimate based on two analysts. The reported number represents a change of +18.1% year over year.

  • Revenue- Market Sector- Industrial: $418 million versus $426.44 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -4.8% change.

View all Key Company Metrics for Plexus here>>>

Shares of Plexus have returned +6.2% over the past month versus the Zacks S&P 500 composite's -3% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Plexus Corp. (PLXS) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research